| |
Latest 10 SEC filings (by transaction date) for GTHX within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 22/24 | Mar 20/24 | Thomas Monica R. | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 37,500 | |
Mar 22/24 | Mar 20/24 | Avagliano Mark | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 100,000 | |
Mar 22/24 | Mar 20/24 | Umstead John W. V | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 37,500 | |
Mar 20/24 | Mar 18/24 | Umstead John W. V | Direct Ownership | Common Stock | S - Open market or private sale | -6,547 | $3.02 |
Feb 13/24 | Feb 12/24 | Malik Rajesh | Direct Ownership | Stock Option (Right to Buy) | M - Exercise or conversion exempt under rule 16b-3 | -28,600 | |
Feb 13/24 | Feb 12/24 | Malik Rajesh | Direct Ownership | Common Stock | S - Open market or private sale | -28,600 | $4.62 |
Feb 13/24 | Feb 12/24 | Malik Rajesh | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 28,600 | $0.300 |
Jan 8/24 | Jan 4/24 | Umstead John W. V | Direct Ownership | Common Stock | S - Open market or private sale | -111 | $2.94 |
Jan 8/24 | Jan 4/24 | Malik Rajesh | Direct Ownership | Common Stock | S - Open market or private sale | -721 | $2.94 |
Jan 8/24 | Jan 4/24 | Avagliano Mark | Direct Ownership | Common Stock | S - Open market or private sale | -721 | $2.94 |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for GTHX within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 22/24 | Mar 20/24 | Thomas Monica R. | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 37,500 | |
Mar 22/24 | Mar 20/24 | Avagliano Mark | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 100,000 | |
Mar 22/24 | Mar 20/24 | Umstead John W. V | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 37,500 | |
Mar 20/24 | Mar 18/24 | Umstead John W. V | Direct Ownership | Common Stock | S - Open market or private sale | -6,547 | $3.02 |
Feb 13/24 | Feb 12/24 | Malik Rajesh | Direct Ownership | Stock Option (Right to Buy) | M - Exercise or conversion exempt under rule 16b-3 | -28,600 | |
Feb 13/24 | Feb 12/24 | Malik Rajesh | Direct Ownership | Common Stock | S - Open market or private sale | -28,600 | $4.62 |
Feb 13/24 | Feb 12/24 | Malik Rajesh | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 28,600 | $0.300 |
Jan 8/24 | Jan 3/24 | Umstead John W. V | Direct Ownership | Stock Options (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 74,500 | |
Jan 8/24 | Jan 4/24 | Umstead John W. V | Direct Ownership | Common Stock | S - Open market or private sale | -111 | $2.94 |
Jan 8/24 | Jan 3/24 | Umstead John W. V | Direct Ownership | Common Stock | S - Open market or private sale | -379 | $3.12 |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Neurocrine Biosciences (OQ:NBIX) |
Regeneron Pharmaceuticals (OQ:REGN) |
Madrigal Pharmaceuticals (OQ:MDGL) |